Prophylactic	O
thyroidectomy	O
in	O
MEN	B-Cancer
IIA	I-Cancer
:	O
does	O
the	O
calcitonin	O
level	O
correlate	O
with	O
tumor	B-Cancer
spread	O
?	O

BACKGROUND	O
:	O
The	O
fate	O
of	O
patients	O
with	O
multiple	B-Cancer
endocrine	I-Cancer
neoplasia	I-Cancer
of	I-Cancer
type	I-Cancer
II	I-Cancer
A	I-Cancer
(	O
MEN	B-Cancer
II	I-Cancer
A	I-Cancer
)	O
is	O
determined	O
by	O
medullary	B-Cancer
thyroid	I-Cancer
carcinoma	I-Cancer
,	O
which	O
occurs	O
in	O
all	O
cases	O
.	O

This	O
has	O
led	O
to	O
the	O
therapeutic	O
concept	O
of	O
prophylactic	O
thyroidectomy	O
in	O
affected	O
family	O
members	O
with	O
the	O
goal	O
of	O
removing	O
the	O
thyroid	B-Organ
before	O
the	O
manifestation	O
of	O
carcinoma	B-Cancer
.	O

We	O
investigated	O
a	O
prophylactically	O
thyroidectomized	O
MEN	B-Cancer
II	I-Cancer
A	I-Cancer
population	O
to	O
determine	O
whether	O
the	O
highly	O
specific	O
and	O
sensitive	O
tumor	B-Cancer
marker	O
calcitonin	O
correlates	O
with	O
tumor	B-Cancer
spread	O
.	O

PATIENTS	O
AND	O
METHODS	O
:	O
Fifteen	O
patients	O
with	O
MEN	B-Cancer
II	I-Cancer
A	I-Cancer
(	O
aged	O
4	O
-	O
24	O
years	O
)	O
who	O
had	O
undergone	O
prophylactic	O
thyroidectomy	O
since	O
1990	O
were	O
included	O
in	O
the	O
study	O
.	O

Baseline	O
and	O
pentagastrin	O
-	O
stimulated	O
calcitonin	O
levels	O
were	O
preoperatively	O
determined	O
in	O
all	O
cases	O
.	O

The	O
indication	O
for	O
surgery	O
was	O
established	O
on	O
the	O
basis	O
of	O
pathologic	O
calcitonin	O
levels	O
in	O
the	O
first	O
seven	O
patients	O
and	O
on	O
the	O
basis	O
of	O
detected	O
RET	O
proto	O
-	O
oncogene	O
mutation	O
in	O
the	O
other	O
eight	O
patients	O
.	O

Bilateral	O
central	O
lymphadenectomy	O
was	O
performed	O
in	O
all	O
patients	O
in	O
addition	O
to	O
thyroidectomy	O
.	O

RESULTS	O
:	O
Histology	O
demonstrated	O
C	B-Cell
-	I-Cell
cell	I-Cell
hyperplasia	O
in	O
five	O
patients	O
(	O
aged	O
4	O
-	O
13	O
years	O
)	O
,	O
unilateral	O
medullary	B-Cancer
microcarcinoma	I-Cancer
in	O
six	O
(	O
aged	O
9	O
-	O
17	O
years	O
)	O
and	O
a	O
bilateral	O
medullary	B-Cancer
microcarcinoma	I-Cancer
in	O
three	O
cases	O
(	O
aged	O
17	O
-	O
24	O
years	O
)	O
.	O

One	O
9	O
-	O
year	O
-	O
old	O
boy	O
with	O
bilateral	O
microcarcinoma	B-Cancer
already	O
had	O
a	O
lymph	B-Multi-tissue_structure
node	I-Multi-tissue_structure
metastasis	O
.	O

The	O
mean	O
baseline	O
calcitonin	O
level	O
correlated	O
with	O
the	O
histologic	O
findings	O
(	O
r	O
=	O
0	O
.	O
71	O
,	O
P	O
=	O
0	O
.	O
003	O
)	O
but	O
there	O
was	O
no	O
correlation	O
between	O
pentagastrin	O
-	O
stimulated	O
calcitonin	O
levels	O
and	O
histology	O
(	O
r	O
=	O
0	O
.	O
21	O
,	O
P	O
=	O
0	O
.	O
47	O
)	O
.	O

CONCLUSION	O
:	O
In	O
MEN	B-Cancer
II	I-Cancer
A	I-Cancer
patients	O
undergoing	O
prophylactic	O
thyroidectomy	O
,	O
baseline	O
but	O
not	O
stimulated	O
calcitonin	O
levels	O
already	O
correlate	O
with	O
the	O
histologic	O
tumor	B-Cancer
stage	O
at	O
the	O
stage	O
of	O
clinically	O
occult	O
C	B-Cell
-	I-Cell
cell	I-Cell
hyperplasia	O
or	O
medullary	B-Cancer
microcarcinoma	I-Cancer
.	O

However	O
,	O
biochemical	O
screening	O
cannot	O
reliably	O
discriminate	O
the	O
transition	O
from	O
C	B-Cell
-	I-Cell
cell	I-Cell
hyperplasia	O
to	O
invasive	B-Cancer
microcarcinoma	I-Cancer
.	O

Individuals	O
with	O
MEN	B-Cancer
IIA	I-Cancer
should	O
therefore	O
undergo	O
early	O
prophylactic	O
thyroidectomy	O
once	O
the	O
diagnosis	O
is	O
confirmed	O
by	O
molecular	O
genetic	O
testing	O
.	O

